Sow Good to acquire Nachu Graphite Project for $107M
Sow Good (NASDAQ:SOWG) announced a transformative strategic shift today, entering into a definitive agreement to acquire 100% of the Tanzanian subsidiaries holding the Nachu Graphite Project.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Sow Good (NASDAQ:SOWG) announced a transformative strategic shift today, entering into a definitive agreement to acquire 100% of the Tanzanian subsidiaries holding the Nachu Graphite Project.
Vicor (NASDAQ:VICR) reported a significant acceleration in demand for its power conversion technologies during the first quarter of 2026, driven by the rapid expansion of AI-related data centers and industrial applications.
RTX (NYSE:RTX), the aerospace and defense titan formerly known as Raytheon Technologies, raised its full-year earnings and sales forecasts following a strong first quarter that saw profit margins expand across its entire portfolio.
UnitedHealth Group (NYSE:UNH) today reported financial results for the first quarter of 2026, delivering growth across its primary business platforms and raising its full-year earnings outlook.
Bitmine Immersion Technologies has acquired 101,627 Ethereum in its largest purchase of 2026, reinforcing its aggressive accumulation strategy.
North Korea-linked hackers have escalated attacks on decentralised finance, siphoning more than $500 million from the Drift and Kelp exploits within just over two weeks.
ZachXBT has publicly challenged MemeCore to justify the valuation and token distribution of its M token, raising concerns about potential insider concentration.
Donald Trump’s public statements and social media posts have repeatedly triggered sharp price swings in Bitcoin, with moves ranging from 5% to 12% within minutes or hours.
Financial services provider HUB24 (ASX:HUB) reported net inflows for the third quarter of the 2026 financial year.
Nexalis Therapeutics (ASX:NX1) announced a clinical breakthrough with the screening of the first patient in its Phase 2 clinical trial for IRX-211.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy